...

首页> 外文期刊>Psycho-Oncology: Journal of the Psychological Social and Behavioral Dimensions of Cancer >Can We Fix What We've Broken? Randomized Controlled Trial of a Group Therapy to Address Body Image Disturbance and Sexuality Following Treatment with Breast Cancer

【24h】

Can We Fix What We've Broken? Randomized Controlled Trial of a Group Therapy to Address Body Image Disturbance and Sexuality Following Treatment with Breast Cancer

机译：我们可以修复已损坏的内容吗？乳腺癌治疗后针对团体形象干扰和性行为的集体疗法的随机对照试验。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Psycho-Oncology: Journal of the Psychological Social and Behavioral Dimensions of Cancer》 |2014年第supplas3期|共1页
作者
Esplen Mary Jane; Wong Jiahui; Warner Ellen; Toner Brenda;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
专利

1. Can We Fix What We've Broken? Randomized Controlled Trial of a Group Therapy to Address Body Image Disturbance and Sexuality Following Treatment with Breast Cancer [J] . Esplen Mary Jane, Wong Jiahui, Warner Ellen, Psycho-Oncology: Journal of the Psychological Social and Behavioral Dimensions of Cancer . 2014,第SupplaS3期

机译：我们可以修复已损坏的内容吗？乳腺癌治疗后针对团体形象干扰和性行为的集体疗法的随机对照试验。
2. A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1 - or BRCA2 -mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protocol for a randomized controlled trial [J] . Philip C. Schouten, Gwen M. H. E. Dackus, Serena Marchetti, Trials . 2016,第1期

机译：I期，然后是随机的II期临床试验，该试验为两个周期的卡铂-奥拉帕尼联合奥拉帕尼单药治疗与卡培他滨联合治疗BRCA1或BRCA2突变的HER2阴性晚期乳腺癌作为一线治疗（REVIVAL）：一项随机对照试验的研究方案
3. A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: study protocol for a randomized controlled trial [J] . Jiemin Zhu, Lyn Ebert, Xiangyu Liu, BMC Cancer . 2017,第1期

机译：乳腺癌电子支持计划与常规护理的移动应用程序在中国接受化疗的乳腺癌女性患者中的治疗：一项随机对照试验的研究方案
4. Deformable image registration as a tool to improve survival prediction after neoadjuvant chemotherapy for breast cancer: Results from the ACRIN 6657/I-SPY-1 trial [C] . Nariman Jahani, Eric Cohen, Meng-Kang Hsieh, SPIE Medical Imaging Conference . 2018

机译：可变形图像配准作为改善乳腺癌新辅助化疗后生存预测的工具：ACRIN 6657 / I-SPY-1试验的结果
5. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
6. A clinical trial of group-based body psychotherapy to improve bodily disturbances in post-treatment cancer patients in combination with randomized controlled smartphone-triggered bodily interventions (KPTK): study protocol [O] . Astrid Grossert, Cornelia Meffert, Viviane Hess, 2019

机译：一项基于团体的身体心理治疗以改善治疗后癌症患者的身体不适的临床试验结合随机控制的智能手机触发的身体干预（KPTK）：研究方案
7. A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in - or -mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protocol for a randomized controlled trial [O] . 2016

机译：I期，然后是两个周期的卡铂-olaparib联合olaparib单药疗法与卡培他滨联合HER2阴性或突变的HER2阴性晚期乳腺癌作为一线治疗（REVIVAL）的随机II期试验：一项随机对照试验的研究方案

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号